Xuefan Q. Yu
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer.
Journal: Oncogene
Published: July 29, 2024
Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.
Journal: Clinical and translational medicine
Published: December 26, 2023
A "One Arrow Three Eagle" Strategy to Improve CM-272 Primed Bladder Cancer Immunotherapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: October 10, 2023
Employing Piezoelectric Mg2+-Doped Hydroxyapatite to Target Death Receptor-Mediated Necroptosis: A Strategy for Amplifying Immune Activation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 27, 2023
China special issue on gastrointestinal tumors-Regulatory-immunoscore-A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer.
Journal: International journal of cancer
Published: October 17, 2022
Comparative efficacy and toxicity of immune checkpoint inhibitors in combination with or without chemotherapy treatment for advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: June 01, 2022
Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells.
Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica
Published: January 25, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026